This summer saw a host of amendments in defense bills to restrict investment in China. Will the rhetoric be met with action?
China companies are put on Entity Lists for being in breach of certain laws. In this case, allegations of forced labor. That doesn’t stop U.S. investors from buying their stocks.
Companies continue to invest in domestic solar thanks to all the new renewable energy tax credits. Without them, and tariffs, US solar would be China owned.
In latest House Select Committee on the CCP, outbound investment restrictions get favorable view.
Trump’s call to reshore pharmaceutical production, especially critical medicine in short supply, will set the table for other presidential candidates. Reshoring America’s medicine supply chain is increasingly mainstream, and an easy sell to voters.
Should federal government employees, including military commanders, be investing their retirement money in China? Some say no, and will try to stop it this week.
The House Select Committee on the CCP held a debate this week with opposing teams arguing for ways to restrict outbound investment to China, including going after Silicon Valley venture capital firms.
Big trouble in China as Washington increasingly warns American businesses to “stay at your own risks”.
Tariffs — and China risks — have helped U.S. reshore and led to more investments in production, shifting the decades old focus away from offshoring.
Some in the Senate want to ban China from government retirement funds. Wall Street thinks it’s their fiduciary duty to be in China, despite losing money.